camostat has been researched along with Peptic Ulcer in 1 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
Peptic Ulcer: Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moriya, S | 1 |
| Omura, N | 1 |
| Kashiwagi, H | 1 |
| Inagaki, Y | 1 |
| Aoki, T | 1 |
1 other study available for camostat and Peptic Ulcer
| Article | Year |
|---|---|
[Treatment of peptic ulcer and reflux esophagitis with enzyme inhibitors].
Topics: Adult; Aged; Esophagitis, Peptic; Esters; Female; Gabexate; Gastric Acid; Guanidines; Humans; Omepra | 1991 |